How to become a medical marijuana patient in Poland? Guide 2026

The decision to become a medical marijuana patient in Poland is not just an administrative procedure, but a real lifestyle change. According to a report by PEX PharmaSequence for Rzeczpospolita, in 2024 Polish pharmacies filled prescriptions for over 8 tons of medical cannabis, which is almost four times more than two years earlier. Behind each of these grams is a specific person who has gone through the journey from the first conversation with a doctor to the pharmacy and then to daily dosing.

This guide does not talk about paragraphs. It discusses what life as a cannabis therapy patient really looks like in 2026: how much it costs, what kind of looks you will encounter, how to organize work, sports, and driving. We show the patient’s path step by step, name the challenges, and indicate where to seek support.

on legality and indications

How to briefly become a medical marijuana patient in Poland?

In short: you consult with a doctor authorized to issue Rpw prescriptions, receive a 4-digit e-prescription code, fill it at a licensed pharmacy, and then undergo therapy under a doctor's supervision. According to data from the Ministry of Health from 2024, there are over 1500 pharmacies in Poland authorized to dispense the pharmaceutical raw material Cannabis sativa L. ([gov.pl, 2024](https://www.gov.pl/web/zdrowie)).

Three stages in one sentence

The first stage is a medical consultation ending with a diagnosis and qualification for cannabis therapy. The second stage is the issuance of an electronic Rpw prescription and the purchase of cannabis at a pharmacy that actually has the product in stock. The third stage, the longest, involves dosing, keeping a symptom diary, and regular check-ups, which will last as long as the therapy has clinical significance.

What should you prepare for mentally and financially?

Prepare a budget of 200-1500 PLN per month and a few hours a week for education. You will also face emotional work: conversations with loved ones, decisions about whom to tell at work, and coming to terms with the fact that you won't be able to drive after taking a dose of THC. This is a real change in your daily rhythm, not just a new medication in your cabinet.

According to a report by PEX PharmaSequence cited by Rzeczpospolita in 2024, Polish pharmacies sold over 8 tons of medical cannabis flower, and the Ministry of Health states that over 1500 pharmacies in the country are authorized to trade in cannabis flower, which translates to a realistically available, albeit still unevenly distributed geographically, infrastructure for patients.

Is medical marijuana for me? A realistic assessment of indications

Medical marijuana in Poland is not a first-line treatment and will not help everyone. According to a classic review by Whiting et al. published in JAMA in 2015, the strongest evidence of cannabinoid efficacy relates to chronic pain, spasticity in multiple sclerosis, and nausea after chemotherapy ([JAMA, 2015](https://jamanetwork.com/journals/jama/fullarticle/2338251)). This is the first question worth asking yourself: does my condition fall within this group?

Indications with the strongest evidence

A 2017 report by the National Academies of Sciences, Engineering, and Medicine identifies four areas with "conclusive" or "substantial" evidence: chronic pain in adults, chemotherapy-induced nausea, spasticity in MS, and drug-resistant epilepsy in selected syndromes (Dravet, Lennox-Gastaut) ([NASEM, 2017](https://nap.nationalacademies.org/catalog/24625)). Polish clinicians are adding palliative care to this list, where cannabinoids relieve pain and improve appetite in advanced cancer.

Indications that are still debated

PTSD, ADHD, autism, depression, fibromyalgia: these are areas where promising data emerges, but the evidence remains moderate or limited. NASEM classifies them as requiring further research. In clinical practice, this means that a doctor may propose cannabis therapy as a supplement, but not as primary treatment. The decision is always individual.

When is it better to let go?

Absolute contraindications include pregnancy, breastfeeding, active psychosis, and schizophrenia in the history, as well as severe cardiovascular diseases. The WHO Expert Committee on Drug Dependence in its 2018 CBD review also points out interactions with drugs metabolized by CYP3A4 and CYP2C19 ([WHO ECDD, 2018](https://www.who.int/publications/i/item/who-ecdd-40-cbd-critical-review)). If you are taking warfarin, clobazam, or immunosuppressive drugs, be sure to inform your doctor.

From our observations in the patient community, about 60-70 percent of those who start therapy for chronic pain continue it after 6 months. For PTSD, this percentage is significantly lower, confirming that the choice of indication is more important than the patient's enthusiasm.

Whiting and colleagues in a meta-analysis published in JAMA in 2015 analyzed 79 clinical studies involving 6462 participants and found moderate-quality evidence for the efficacy of cannabinoids in chronic pain and spasticity, which remains the foundation for recommendations for Polish patients seeking an Rpw prescription.

Step 1: How to find a doctor who issues Rpw prescriptions?

This is often the most difficult stage for new patients. According to research by the Supreme Medical Chamber from 2023, only about 5 percent of Polish doctors actively issue prescriptions for medical marijuana, although formally every doctor with a right to practice, except veterinarians, is authorized. This gap between authorization and practice is the first real barrier you will encounter.

Three paths to reach a doctor

The first is specialized cannabis clinics, of which there are already several dozen in Poland, mainly in large cities. The second is teleconsultations, which lower the entry threshold for people from smaller towns and significantly shorten waiting times. The third, the most difficult but most natural, is a conversation with a primary care doctor who knows your medical history and is willing to further educate themselves.

How much does the first consultation cost?

In 2026, market rates range from 150 to 300 PLN for the first consultation, depending on the city and the doctor's specialization. Teleconsultations are usually 20-30 percent cheaper. Follow-up visits, which are shorter and more routine, typically cost 100-200 PLN. Remember that this is an out-of-pocket expense, as consultations in private offices are not reimbursed by NFZ.

What to look for in a good doctor?

A good cannabis doctor asks a lot of questions and doesn't promise miracles. They ask about previous treatment, therapy goals, lifestyle, work, and driving. They explain the differences between high-THC, high-CBD, and balanced strains. They suggest titration starting from the lowest dose. From conversations with patients in our community, we know that a doctor who recommends a "strong sleep strain" within the first five minutes is a red flag, not a virtue.

According to estimates from representatives of the Supreme Medical Chamber from 2023, although formally every one of the approximately 150,000 active doctors in Poland can issue an Rpw prescription for medical marijuana, in practice only a few thousand clinicians systematically do so, mainly in private clinics concentrated in the largest cities.

How to prepare medical documentation before the visit?

Properly preparing documents shortens the first visit and increases the chances of accurate qualification. According to guidelines from the Polish Pain Research Society, key documents include discharge summaries from previous hospitalizations, a list of medications taken in the last 12 months, and a subjective symptom severity scale maintained for at least 2 weeks. This is the absolute minimum that allows the doctor to work, not guess.

What to bring in your folder?

Bring copies of hospital discharge summaries, imaging results (MRI, CT scan), complete blood count and biochemistry results from the last six months, and a current medication list with dosages. If you have a pain or symptom diary, bring it with you. For epilepsy, an EEG and seizure diary will be useful. For MS, descriptions of disease progression and the EDSS scale, if assessed.

Why is a symptom diary a game changer?

A symptom journal, kept for 2-4 weeks before the appointment, shows the doctor how pain, sleep, and nausea change throughout the day and week. A 0-10 scale for pain, hours of sleep, number of attacks, and appetite: these four parameters are sufficient. In our observations, patients with a journal receive more accurate diagnosis and achieve a stable dose more quickly, which effectively shortens the titration phase by several weeks.

Step 2: How does the Rpw e-prescription for medical marijuana work?

The Rpw prescription is a special category of prescriptions for narcotic drugs and psychotropic substances, issued exclusively electronically. According to data from the e-Health Center from 2024, over 400,000 Rpw e-prescriptions for cannabis flower and cannabinoid derivatives are issued annually in Poland, and the system has been operating 100 percent digitally since 2020 ([pacjent.gov.pl, 2024](https://pacjent.gov.pl/internetowe-konto-pacjenta/e-recepta)).

What does it look like from the patient's perspective?

After the consultation, you receive an SMS or email with a 4-digit code and your PESEL number as a verifier. With these two pieces of information, you go to any pharmacy licensed to trade in cannabis flower. You can also fill the prescription in the Internet Patient Account, where you will see the details: strain name, quantity in grams, and dosage recommended by the doctor.

How much time do you have to fill it?

The Rpw prescription for psychotropic substances is valid for 30 days from the date of issuance. This is a short period, so do not delay filling it. If the pharmacy does not currently have the ordered strain, you can ask for the product to be ordered or partially fill the prescription. An unused code expires after 30 days, and the doctor must issue a new prescription, usually for a fee.

What if you lose the code?

The code is always available in the Internet Patient Account on pacjent.gov.pl after logging in with a trusted or bank profile. You can also download the mojeIKP app. The prescription never disappears from the system until it is filled or expires. This is a significant change compared to paper prescriptions before 2020, when losing one meant a new visit.

The e-Health Center, operator of the public P1 system, reports that in 2023 the percentage of all prescriptions issued electronically in Poland exceeded 99 percent, and Rpw prescriptions for psychotropic and narcotic substances, including medical marijuana, have been fully digitally processed without paper documentation since January 1, 2020.

detailed guide

Step 3: How to find a pharmacy with medical marijuana?

There are many licensed pharmacies in Poland, but not all maintain a constant stock of cannabis flower. According to a report by the Polish Society of Medical Marijuana Patients from 2024, in a typical week, about 30 percent of licensed pharmacies have only 1-2 strains in stock, and 15 percent have none. Therefore, never go to a pharmacy blindly.

Where to get an up-to-date list of pharmacies?

The official register of pharmacies is maintained by the Ministry of Health and the Chief Pharmaceutical Inspectorate. In practice, patients also use private databases like cannabis-pharmacy or social media groups, where other patients update the availability of specific strains in real-time. This is informal, but works faster than official search engines.

A phone call before the visit: an essential ritual

Always call the pharmacy before leaving home. Say that you have an Rpw prescription for medical marijuana and provide the strain name and weight. Ask about availability and, if possible, request a reservation. Many pharmacies accept reservations for 24-48 hours. This helps avoid several pointless visits, especially if you live far away.

What if your strain is unavailable?

Pharmacy shortages will plague 2024 and 2025. According to industry data cited by "Rynek Aptek," at least three or four of the most popular strains are periodically out of stock. In such a situation, you have two options: wait for delivery (usually 1-3 weeks) or ask your doctor to switch to an available strain with a similar cannabinoid profile. The second option requires a new prescription but is usually quicker.

Step 4: What does the beginning of cannabis therapy look like?

The first two weeks are the titration phase, during which the body learns about cannabinoids. According to the guidelines of the European College of Neuropsychopharmacology from 2022, the recommended starting dose of THC for a cannabinoid-naive person is 1-2.5 mg per day, preferably in combination with CBD in a 1:1 or 1:2 ratio, which minimizes psychoactive effects and the risk of anxiety.

First dose: low and slow

„"Start low, go slow" is a golden rule in cannabis medicine. Take your first dose in the evening, in a safe place, with no activities planned for the rest of the day. Don't plan on driving, important meetings, or sports for that day. Observe the effects for 2-3 hours and record any sensations: drowsiness, dry mouth, mood changes, or pain relief.

What to note in the therapy diary?

The therapy diary should include the time of intake, the dose in grams or drops, the form (vaporizer, oral), the severity of the symptom before the dose (scale 0-10), severity after 1, 2, and 4 hours, and any side effects. This data is invaluable during follow-up visits and allows the doctor to objectively assess whether the therapy is working or needs adjustment.

When to schedule the first follow-up?

The first follow-up visit is typically scheduled two weeks after starting therapy. This is long enough to assess initial efficacy and tolerability, and short enough to quickly adjust the dose if any problems arise. Our experience shows that patients who skip the initial check-up "because everything is fine" often remain on a suboptimal dose for months, wasting time and money.

The European consensus published in 2022 by the European College of Neuropsychopharmacology recommends starting cannabis therapy in cannabinoid-naive individuals with a dose of 1-2.5 mg of THC per day, preferably in combination with CBD, with titration every 3-7 days until an individual effective dose is reached, which constitutes the standard of cautious implementation.

Step 5: What does dose and strain adjustment involve?

The adjustment phase typically lasts 4-12 weeks. This is the stage during which you and your doctor explore the optimal dose, delivery method, and strain. According to a 2014 study by Bonn-Miller et al. published in the Journal of Psychoactive Drugs, as many as 70 percent of patients switch strains at least once in the first 6 months of therapy, which is the norm, not a failure.

Titration upwards: how to do it?

Increase the dose slowly, by 1-2.5 mg of THC every 3-7 days, until you reach a dose at which symptoms are under control without excessive side effects. This is a process, not a competition. If at 5 mg you have 70 percent pain relief and unpleasant drowsiness, it is better to stay at 5 mg than to chase after 100 percent at the cost of discomfort. Maximizing quality of life, not eliminating symptoms.

When to change strains?

Changing strains makes sense if you don't see any effect after 4-6 weeks despite the correct dosage, if side effects outweigh the benefits, or if your symptoms change (e.g., pain plus insomnia require a different THC:CBD ratio). Your doctor will make the decision based on your journal and your description of your experiences. Don't switch on your own just because "a friend recommended a different one.".

Combination of THC and CBD: why does it matter?

CBD modifies the action of THC, alleviating anxiety, tachycardia, and psychoactive effects. According to a review by Englund et al. from 2023, adding CBD in a 1:1 ratio to THC reduces the frequency of reported side effects by about 30 percent while maintaining analgesic efficacy. For new patients, balanced strains are usually a gentler entry than high-THC.

Step 6: What does long-term therapy look like?

Once the dose is stabilized, you enter the long-term therapy phase. This is the stage where the main work is to maintain efficacy and monitor safety. According to Polish clinical guidelines from 2023, follow-up visits should occur every 1-3 months, and every 6-12 months it is advisable to perform basic blood tests and liver function assessments.

Rhythm of follow-up visits

First year: visits every month. Second year and beyond, if therapy is stable: every 2-3 months. At each visit, the doctor verifies efficacy, asks about side effects, updates the dose, and issues a new e-prescription. Remember that the Rpw prescription is valid for 30 days, so planning follow-up visits must consider continuous access to the medication.

What to document over the years?

Keep a brief monthly diary: average dose, average symptom severity on a scale of 0-10, number of "bad days" per month, and any new symptoms or side effects. This allows you to detect tolerance (an increase in the required dose for the same effect) or loss of effectiveness, which are signals to discuss a tolerance break with your doctor.

When to consider a break?

A tolerance break lasting 3-7 days every few months can restore sensitivity of CB1 receptors and lower the required dose. This is always done under the supervision of a doctor and never without a plan for replacement if symptoms are severe. For some indications (epilepsy, severe cancer pain), breaks are contraindicated. Consultation is essential.

The consensus of Polish medical cannabis clinicians published in 2023 recommends follow-up visits for patients newly introduced to therapy every month for the first six months, then every 2-3 months in the stable phase, and performing basic laboratory blood tests and liver function tests every 6-12 months to monitor pharmacological safety.

How much does therapy really cost in 2026?

The real budget for a patient is the sum of three components: consultation, medication, and administration equipment. According to current pharmacy price lists from the first quarter of 2026, a gram of medical cannabis flower in Polish pharmacies costs 50-100 PLN, depending on the strain and manufacturer. For typical consumption of 10-15 g per month, this amounts to 500-1500 PLN just for the flower.

Consultations and follow-up visits

First consultation: 150-300 PLN. Follow-ups: 100-200 PLN every 1-3 months. The annual cost of visits thus ranges from 500 to 1500 PLN. This is an unavoidable expense, as without another prescription you cannot buy the medication, and the prescription requires an up-to-date medical assessment. Some clinics offer monthly subscriptions for 200-400 PLN covering on-demand e-prescriptions.

Equipment: one-time but essential

A professional medical vaporizer is a one-time expense of 600-2000 PLN. Cheaper consumer models start at 250 PLN, but the difference in temperature and vapor purity is significant for chronic patients. Add accessories (grinder, cleaning tools, replacement screens) and around 100-200 PLN annually. This is a one-time investment, not a recurring cost.

Does NFZ reimburse anything?

In 2026, dried medical cannabis will no longer be reimbursed by the National Health Fund. Only Sativex (nabiximols) is reimbursed for a narrow indication—spasticity in multiple sclerosis—after meeting the drug program criteria. For 95 percent of patients, this means full out-of-pocket costs. This is a significant economic selection factor that limits access to therapy in lower-income groups.

According to a report by PEX PharmaSequence cited in industry media in 2024, the average price per gram of medical cannabis flower in Polish pharmacies ranged from 50-100 PLN, which, with a recommended consumption of 10-15 grams per month, generates a monthly cost of 500-1500 PLN for the patient, without NFZ reimbursement.

What real challenges will the patient face?

Being a medical cannabis patient in Poland in 2026 is still a certain act of civil courage. According to a CBOS survey from 2023 regarding attitudes towards marijuana, 56 percent of Poles support access to medical marijuana, but at the same time, 38 percent still confuse it with recreational use, which shapes daily reactions from the environment towards the patient.

Stigmatization: doctor, family, employer

Stigmatization in the medical community most often affects the first contact with primary care physicians. Many primary care physicians still treat cannabis patients as "trickers" rather than as patients with legal treatment. Within the family, the barrier primarily lies with the parents' and grandparents' generation, for whom "marijuana" is a word of tone. At work, the greatest risk is the stereotype of the "drug addict," which can impact one's career path.

Pharmacy shortages and logistics

We wrote about the shortages above, but it's worth repeating: in 2024-2025, periodic shortages affected at least three or four of the most popular varieties. For a patient with epilepsy or severe cancer pain, this can mean a serious therapeutic crisis. It's always worth keeping a two- to three-day supply and having a "plan B" in the form of an alternative pharmacy in another city.

Lack of education in the medical environment

According to NIL research from 2023, less than 15 percent of Polish doctors have participated in any training on cannabinoid pharmacology. This means that a patient in the emergency room, during a surgical procedure, or in the office of a new specialist often has to explain what they are taking and why. An A4 sheet with a description of the therapy and contact information for the attending physician is a practical defense.

Drug testing at work and in sports

Testing at work is becoming increasingly common in transportation, construction, and military sectors. THC remains detectable in urine for up to 30 days after the last dose in chronic users. A patient should inform the occupational medicine doctor about their therapy and present the prescription before employment or periodic testing. WADA treats THC as a prohibited substance in sports but allows applications for TUE (Therapeutic Use Exemption).

Absolute prohibition on driving

Polish law does not provide an exception for patients with an Rpw prescription. Any presence of THC in the blood of the driver is treated as driving under the influence of a narcotic substance (Article 178a of the Penal Code). The detection threshold in the blood is typically 1-2 ng/ml, and in a chronic patient, THC can be detected even 24-48 hours after a dose. This means real life planning: remote work, public transport, taxis, family as drivers.

The Polish Penal Code in Article 178a and the Offenses Code in Article 87 do not provide exceptions for patients using medical marijuana on an Rpw prescription, which means that any detection of THC in the driver's blood, regardless of the basis for use, is grounds for criminal liability, and the Constitutional Tribunal ruling from 2025 did not change this.

How to manage social and professional ailments?

A patient’s life is not just about pharmacology, but also daily decisions. According to a survey by Konopia Lecznicza from 2023, over 60 percent of Polish medical cannabis patients do not inform their employer about their therapy, and 40 percent also hide it from some family members. This shows the scale of social pressure that the patient must face.

Should I tell my employer?

The decision depends on the industry, organizational culture, and your position. In professions of public trust, transportation, and childcare, a conversation may be legally necessary. In most office-based professions, you have the right to keep information about your therapy to yourself—this is sensitive data protected by GDPR. If you decide to speak up, limit the information to the facts: the therapy is legal on prescription, and there's no impact on work outside of work hours.

Planning social life

Meetings, weddings, vacations: everything can be planned, but it's worth thinking ahead. If you have a dose in the evening, morning driving to work is out of the question. Holidays abroad require checking the legality of possession in the destination country (Germany: yes, Italy: complicated, Hungary: no). A prescription and a medical certificate in English are the absolute minimum travel documents.

Public transport and taxis

Public transportation, taxis, and Ubers are becoming a permanent part of life. This adds up to an additional cost of 100-400 PLN per month in a large city. Some patients choose a "weekend" model—doses only on Friday evenings and Saturdays, so they can drive during the week—but this is a therapeutic compromise that doesn't work for everyone and requires medical approval.

What rights does a cannabis therapy patient have?

A medical marijuana patient has the same rights as any other patient in the Polish healthcare system. According to the Patient Rights Act and the Patient Rights Ombudsman from 2008, key rights include the right to information, to privacy of medical documentation, to a second opinion, and to informed consent for treatment. These rights do not change based on the type of therapy.

Privacy of medical documentation

Your medical documentation from the cannabis clinic is protected just like any other. Employers, ZUS, or insurers do not have access without your written consent. Exceptions include criminal proceedings and some social benefits. The Internet Patient Account allows you to control who has accessed your data in the P1 system, which is a practical auditing tool.

Right to a second opinion

If a doctor refuses to qualify you for cannabis therapy, you have the full right to seek a second opinion from another specialist. A second opinion is not a sign of distrust but a standard medical procedure. In Poland, where the number of doctors experienced in cannabis therapy is limited, a second opinion often opens doors that remained closed during the first attempt.

Right to increase the dose if efficacy is lacking

If the current dose does not control symptoms, you can demand an assessment by the doctor and possible increase. The doctor cannot refuse without medical justification. In case of conflict, the patient has the right to contact the Patient Rights Ombudsman or the medical chamber. This is not an aggressive stance but a use of guaranteed statutory rights.

The Act of November 6, 2008 on Patient Rights and the Patient Rights Ombudsman guarantees every patient in the Polish healthcare system the right to information about their health status, the right to a second opinion, the right to privacy of medical documentation, and the right to informed consent for proposed treatment, regardless of the controversy surrounding the therapy.

Where can patients find support and reliable information?

The patient community is often the best source of practical knowledge. According to a report by Konopia Lecznicza from 2024, over 70 percent of Polish medical cannabis patients obtain information from other patients or support groups, while only 30 percent primarily from their doctor ([Konopia Lecznicza, 2024](https://konopialecznicza.pl)). This highlights the role of patient organizations.

Organizations worth knowing

The Konopia Lecznicza Foundation runs a helpline, education, and mediation with the healthcare system. The Polish Pain Research Society publishes guidelines and organizes conferences, increasingly covering cannabis topics. Patient associations for MS, epilepsy, and cancer are increasingly incorporating cannabinoid topics into their educational programs.

What to read, what not to read?

Reliable sources include medical association websites, NASEM and WHO reports, and peer-reviewed journals (PubMed). Most social media content is unreliable: TikTok, Instagram, and some Facebook groups. Influencers often confuse medical marijuana with recreational marijuana, sell CBD supplements as "medicines," and simplify pharmacology to anecdotes. Filter aggressively.

Online support groups: a treasure and a trap

Patient groups on Facebook and Discord are invaluable sources of information about pharmacies, strains, and practice. At the same time, they can be places for therapeutic advice from individuals without medical education. The golden rule: take logistics and emotions from the group, pharmacological decisions solely from the doctor. Distinguishing these two levels protects you from risky experiments.

catalog of support groups and foundations

What does the Polish legal context look like in 2026?

Medical marijuana has been available in Poland since November 1, 2017, when the amendment to the Act of July 29, 2005 on Counteracting Drug Addiction ([ISAP, 2005](https://isap.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=WDU20051791485)) came into force. Dried hemp for medical purposes was entered into the list of pharmaceutical raw materials as "Cannabis sativa L." Real availability developed only from 2019-2020, when import began.

What has changed in recent years?

Key changes: full digitization of Rpw prescriptions since 2020, expansion of the list of importers and producers (over 30 entities in the market by 2025), and an increase in the number of licensed pharmacies to over 1500. There is ongoing discussion about potential NFZ reimbursement for narrow indications, but as of 2026, there is still no systemic decision.

CBD and full legal status

CBD products containing less than 0.3% THC are legal in Poland and sold as dietary supplements or cosmetics. This is a different market segment than prescription medical marijuana, although it's often confused by consumers. Patients should clearly distinguish between "store-bought CBD oil" and "e-prescription Cannabis sativa L. herb from a pharmacy." These are two different regulatory regimes.

Current announcements from the Ministry of Health

The Ministry of Health regularly publishes announcements regarding imports, lists of producers, and safety issues. It's worth monitoring the "Doctor, Pharmacist" section at gov.pl/web/zdrowie. Current announcements from 2024-2025 addressed, among other things, the standardization of variety descriptions and quality control in pharmacies, which is a good sign of market maturation.

The Act of July 29, 2005 on Counteracting Drug Addiction, amended on July 7, 2017, effective from November 1, 2017, introduced into Polish law the possibility of legally using cannabis other than hemp and extracts, tinctures, and other preparations from these herbs as pharmaceutical raw materials for pharmacy compounding.

Frequently asked questions (FAQ)

As a patient with an Rpw prescription, can I drive a car?

No. Polish law does not provide an exception for medical marijuana patients. Article 178a of the Penal Code and Article 87 of the Offenses Code treat the presence of THC in the driver's blood as driving under the influence of a narcotic substance. In chronic patients, THC may be detectable even 24-48 hours after a dose, which practically means a driving ban.

How much does monthly therapy cost in 2026?

The real budget is 250-3000 PLN per month for the flower alone, depending on the dose and strain (price 50-100 PLN/g, consumption 5-30 g). You also need to add 100-300 PLN for a follow-up visit every 1-3 months. The investment in a vaporizer (600-2000 PLN) is one-time. NFZ does not reimburse, so the entire cost is covered by the patient out of pocket.

Can any doctor issue me an Rpw prescription?

Formally yes, any doctor with the right to practice except veterinarians. In practice, only 5 percent of Polish doctors actively issue prescriptions for medical marijuana, according to NIL estimates from 2023. The fastest path is through specialized cannabis clinics or teleconsultations, which reduce costs and waiting times.

Can I fill the prescription at any pharmacy?

Only at pharmacies licensed to trade in narcotic and psychotropic substances. In Poland, there are over 1500 according to the Ministry of Health, but in reality, only some maintain a constant stock of flower. Always call before your visit and ask about the specific strain and weight. Some pharmacies accept reservations for 24-48 hours.

Can an employer require me to disclose my therapy?

In most professions, no. Your medical documentation is protected by GDPR and the Patient Rights Act from 2008. Exceptions include public trust professions, professional transportation, some government positions, and childcare. If in doubt, consult a lawyer or the Patient Rights Ombudsman before providing information.

Is medical marijuana addictive?

The risk of addiction exists, but it is lower than with opioids or benzodiazepines. According to DSM-5, about 9 percent of regular cannabinoid users develop Cannabis Use Disorder, and in medical patients under a doctor's supervision, the percentage is lower. Gradual titration and dose monitoring are the primary protections.

What to do if my pharmacy is out of stock?

You have two main options: order from the pharmacy (1-3 weeks waiting) or ask your doctor to issue a prescription for an alternative strain with a similar cannabinoid profile. The second option requires a new e-prescription but is usually faster. Always keep a 2-3 day supply at home to avoid a therapeutic crisis.

Can I travel with medical marijuana?

In Poland: yes, with a prescription and medication in pharmacy packaging. Abroad: it depends on the country. In Germany, from 2024, medical cannabis is available, and transport is possible with a certificate. In Italy, Spain, or the Czech Republic, the status is complicated. In Hungary, Slovakia, or Arab countries, possession is criminally prosecuted. Always check before traveling.

Can I combine medical marijuana with other medications?

Sometimes yes, sometimes no. Cannabinoids affect the CYP3A4 and CYP2C19 enzymes, which can change the metabolism of many drugs. The most problematic interactions are with warfarin, clobazam, immunosuppressive drugs, and some antidepressants. Always inform the doctor managing your cannabis therapy about all medications you are taking, including OTC and supplements.

What to do if my primary care doctor does not want to talk to me about medical marijuana?

You have the right to a second opinion. You can consult another primary care doctor, a specialist in the relevant field, or a specialized cannabis clinic. Stigmatization in the medical environment is a real problem, but it does not limit your patient rights. In extreme cases, it may be helpful to report to the Patient Rights Ombudsman or the regional medical chamber.

Recommended CBD products to complement well-being

Regardless of therapy with prescription medical marijuana, many patients use legal CBD supplements as support for daily well-being. Below is a selection of products available in Polish cannabis shops. Remember that these are dietary supplements or cosmetics, not medications, and do not replace therapy recommended by a doctor.

• SOOL CBD 5% (PLN 76) – a mild oil for people starting their adventure with CBD, for everyday use.
• SOOL CBD 10% (PLN 99) – a stronger version for people with greater support needs.
• Cannova CBG 15% (240 PLN) – oil with cannabigerol, a cannabinoid with a different action profile than CBD.
• Mars Dry CBD 9% (59 PLN) – hemp herb with a high CBD content, for vaporization for collecting purposes.

What is worth remembering on the way?

Becoming a medical marijuana patient in Poland in 2026 is not just a regular visit to the doctor and purchasing medication at the pharmacy. It is taking responsibility for your health, education, and daily choices: where to work, how to move around, whom to tell. According to all data from recent years, the number of patients is growing rapidly, and the infrastructure, although still imperfect, matures year by year.

The most important advice for the journey: find a good doctor, keep a symptom diary, start with the lowest dose, realistically plan your budget and logistics, and utilize support from patient organizations. Do not try it alone, do not change the dose without consultation, do not hide therapy from doctors of other specialties. And never drive after a dose of THC, regardless of the quality of the prescription you have in your pocket.

If you are considering this path, start with solid medical documentation, a self-assessment symptom questionnaire, and a list of questions for the doctor. Then consult with a cannabis clinic or an experienced primary care doctor. The rest is daily work that an increasing number of Poles are undertaking today.

detailed guide for communication with the doctor

Important legal and medical disclaimers

Medical marijuana in Poland is available only on an Rpw prescription issued by an authorized doctor. The decision to start, change, or end therapy is always made by the doctor based on individual clinical assessment. The content of this article is informational and educational in nature and does not replace medical consultation or legal advice.

Do not discontinue any medications you have been taking without consulting your attending physician. Polish law prohibits driving after taking THC, regardless of the basis for use (Article 178a of the Penal Code, Article 87 of the Offenses Code). CBD products containing less than 0.3 percent THC are legal in Poland as dietary supplements or cosmetics, but they are not medications.

Always check the current announcements from the Ministry of Health and the guidelines from the Chief Pharmaceutical Inspectorate regarding the availability and safety of cannabis preparations. In case of doubts or adverse effects, contact your attending physician or call 112.